Regeneron Pharmaceuticals Inc (NASDAQ:REGN) under-valued by 7%
| Website | https://www.regeneron.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $62,258,471,000 |
| Beta | 0.40139 |
| Average Volume | $852,186 |
| Last Dividend | 0% |
| Price on Aug 5, 2020 | $600.82 |
| Autochartist™ Valuation | $644.81 |
| Conclusion |
7% under-valued |
| Download Report |
